These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 22038530)

  • 1. GUCY2C-targeted cancer immunotherapy: past, present and future.
    Snook AE; Magee MS; Waldman SA
    Immunol Res; 2011 Dec; 51(2-3):161-9. PubMed ID: 22038530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor radiation therapy creates therapeutic vaccine responses to the colorectal cancer antigen GUCY2C.
    Witek M; Blomain ES; Magee MS; Xiang B; Waldman SA; Snook AE
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1188-95. PubMed ID: 24661671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prime-Boost Immunization Eliminates Metastatic Colorectal Cancer by Producing High-Avidity Effector CD8
    Xiang B; Baybutt TR; Berman-Booty L; Magee MS; Waldman SA; Alexeev VY; Snook AE
    J Immunol; 2017 May; 198(9):3507-3514. PubMed ID: 28341670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitope-targeted cytotoxic T cells mediate lineage-specific antitumor efficacy induced by the cancer mucosa antigen GUCY2C.
    Snook AE; Magee MS; Marszalowicz GP; Schulz S; Waldman SA
    Cancer Immunol Immunother; 2012 May; 61(5):713-23. PubMed ID: 22057677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical Evaluation of a Replication-Deficient Recombinant Adenovirus Serotype 5 Vaccine Expressing Guanylate Cyclase C and the PADRE T-helper Epitope.
    Snook AE; Baybutt TR; Hyslop T; Waldman SA
    Hum Gene Ther Methods; 2016 Dec; 27(6):238-250. PubMed ID: 27903079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Split tolerance permits safe Ad5-GUCY2C-PADRE vaccine-induced T-cell responses in colon cancer patients.
    Snook AE; Baybutt TR; Xiang B; Abraham TS; Flickinger JC; Hyslop T; Zhan T; Kraft WK; Sato T; Waldman SA
    J Immunother Cancer; 2019 Apr; 7(1):104. PubMed ID: 31010434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guanylate cyclase C as a target for prevention, detection, and therapy in colorectal cancer.
    Aka AA; Rappaport JA; Pattison AM; Sato T; Snook AE; Waldman SA
    Expert Rev Clin Pharmacol; 2017 May; 10(5):549-557. PubMed ID: 28162021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GUCY2C: at the intersection of obesity and cancer.
    Kim GW; Lin JE; Waldman SA
    Trends Endocrinol Metab; 2013 Apr; 24(4):165-73. PubMed ID: 23375388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Heat-Stable Enterotoxin Receptor, Guanylyl Cyclase C, as a Pharmacological Target in Colorectal Cancer Immunotherapy: A Bench-to-Bedside Current Report.
    Baybutt TR; Aka AA; Snook AE
    Toxins (Basel); 2017 Sep; 9(9):. PubMed ID: 28914772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GUCY2C lysosomotropic endocytosis delivers immunotoxin therapy to metastatic colorectal cancer.
    Marszalowicz GP; Snook AE; Magee MS; Merlino D; Berman-Booty LD; Waldman SA
    Oncotarget; 2014 Oct; 5(19):9460-71. PubMed ID: 25294806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An update on guanylyl cyclase C in the diagnosis, chemoprevention, and treatment of colorectal cancer.
    Rappaport JA; Waldman SA
    Expert Rev Clin Pharmacol; 2020 Oct; 13(10):1125-1137. PubMed ID: 32945718
    [No Abstract]   [Full Text] [Related]  

  • 12. Human GUCY2C-Targeted Chimeric Antigen Receptor (CAR)-Expressing T Cells Eliminate Colorectal Cancer Metastases.
    Magee MS; Abraham TS; Baybutt TR; Flickinger JC; Ridge NA; Marszalowicz GP; Prajapati P; Hersperger AR; Waldman SA; Snook AE
    Cancer Immunol Res; 2018 May; 6(5):509-516. PubMed ID: 29615399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric Ad5.F35 vector evades anti-adenovirus serotype 5 neutralization opposing GUCY2C-targeted antitumor immunity.
    Flickinger JC; Singh J; Carlson R; Leong E; Baybutt TR; Barton J; Caparosa E; Pattison A; Rappaport JA; Roh J; Zhan T; Bashir B; Waldman SA; Snook AE
    J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32819976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guanylyl cyclase C as a biomarker for immunotherapies for the treatment of gastrointestinal malignancies.
    Flickinger JC; Rappaport JA; Barton JR; Baybutt TR; Pattison AM; Snook AE; Waldman SA
    Biomark Med; 2021 Feb; 15(3):201-217. PubMed ID: 33470843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A uroguanylin-GUCY2C endocrine axis regulates feeding in mice.
    Valentino MA; Lin JE; Snook AE; Li P; Kim GW; Marszalowicz G; Magee MS; Hyslop T; Schulz S; Waldman SA
    J Clin Invest; 2011 Sep; 121(9):3578-88. PubMed ID: 21865642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-independent activation is critical for the durable antitumor effect of GUCY2C-targeted CAR-T cells.
    Qi C; Liu D; Liu C; Wei X; Ma M; Lu X; Tao M; Zhang C; Wang X; He T; Li J; Dai F; Ding Y; Shen L
    J Immunother Cancer; 2024 Oct; 12(10):. PubMed ID: 39366753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GUCY2C ligand replacement to prevent colorectal cancer.
    Blomain ES; Pattison AM; Waldman SA
    Cancer Biol Ther; 2016 Jul; 17(7):713-8. PubMed ID: 27104761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of GUCY2C expression in lymph nodes with time to recurrence and disease-free survival in pN0 colorectal cancer.
    Waldman SA; Hyslop T; Schulz S; Barkun A; Nielsen K; Haaf J; Bonaccorso C; Li Y; Weinberg DS
    JAMA; 2009 Feb; 301(7):745-52. PubMed ID: 19224751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meconium ileus caused by mutations in GUCY2C, encoding the CFTR-activating guanylate cyclase 2C.
    Romi H; Cohen I; Landau D; Alkrinawi S; Yerushalmi B; Hershkovitz R; Newman-Heiman N; Cutting GR; Ofir R; Sivan S; Birk OS
    Am J Hum Genet; 2012 May; 90(5):893-9. PubMed ID: 22521417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity-Induced Colorectal Cancer Is Driven by Caloric Silencing of the Guanylin-GUCY2C Paracrine Signaling Axis.
    Lin JE; Colon-Gonzalez F; Blomain E; Kim GW; Aing A; Stoecker B; Rock J; Snook AE; Zhan T; Hyslop TM; Tomczak M; Blumberg RS; Waldman SA
    Cancer Res; 2016 Jan; 76(2):339-46. PubMed ID: 26773096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.